TMCI
HEALTHCARETreace Medical Concepts Inc
$1.93+0.05 (+2.66%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving TMCI Today?
No stock-specific AI insight has been generated for TMCI yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$1.17$7.78
$1.93
Fundamentals
Market Cap$124M
P/E Ratio—
EPS$-0.93
Dividend Yield—
Dividend / Share—
ROE-0.6%
Profit Margin-0.3%
Debt / Equity—
Trading
Volume184K
Avg Volume (10D)—
Shares Outstanding64.8M
TMCI News
20 articles- How The Treace Medical Concepts (TMCI) Story Is Shifting With Mixed Analyst ExpectationsYahoo Finance·May 3, 2026
- Treace to Report First Quarter 2026 Financial Results on May 8, 2026Yahoo Finance·Apr 24, 2026
- How The Treace Medical Concepts (TMCI) Narrative Is Shifting With New Targets And Product PlansYahoo Finance·Apr 17, 2026
- Akebia Therapeutics Leads The Pack Of 3 Promising Penny StocksYahoo Finance·Apr 13, 2026
- Artivion (AORT) Soars 5.3%: Is Further Upside Left in the Stock?Yahoo Finance·Apr 8, 2026
- Treace Announces First Surgical Cases with the SuperBite™ Compression Screw SystemYahoo Finance·Apr 7, 2026
- How The Story Is Shifting For Treace Medical Concepts (TMCI) After Analyst Target ResetsYahoo Finance·Mar 20, 2026
- Treace Medical Concepts, Inc. Q4 2025 Earnings Call SummaryMoby·Feb 28, 2026
- Treace Medical Concepts Inc (TMCI) Q4 2025 Earnings Call Highlights: Navigating Challenges with ...Yahoo Finance·Feb 27, 2026
- Treace Medical Concepts Q4 Earnings Call HighlightsMarketbeat·Feb 27, 2026
- Treace Medical Concepts: Q4 Earnings SnapshotYahoo Finance·Feb 27, 2026
- Treace Medical Concepts Reports Fourth Quarter and Full-Year 2025 Financial ResultsYahoo Finance·Feb 27, 2026
- UFP Technologies (UFPT) Q4 Earnings Top EstimatesYahoo Finance·Feb 25, 2026
- Treace Highlights New Product Innovations and Updated Positive Clinical Study Data at the 2026 ACFAS Annual Scientific ConferenceYahoo Finance·Feb 24, 2026
- What Catalysts Are Shifting The Narrative For Treace Medical Concepts (TMCI)?Yahoo Finance·Feb 18, 2026
- Treace Updates Date of Fourth Quarter and Full-Year 2025 Financial Results Release to February 27, 2026Yahoo Finance·Feb 12, 2026
- Stifel Revises Treace Medical Concepts, Inc. (TMCI) Price Target in Sector-Wide UpdateYahoo Finance·Feb 9, 2026
- Reassessing The Narrative For Treace Medical Concepts (TMCI) After Target Cuts And Uneven DemandYahoo Finance·Feb 4, 2026
- How New Analyst Targets Are Reframing The Treace Medical Concepts (TMCI) Investment StoryYahoo Finance·Jan 21, 2026
- Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2025 RevenueYahoo Finance·Jan 13, 2026
All 20 articles loaded
Price Data
Open$1.91
Previous Close$1.88
Day High$1.97
Day Low$1.84
52 Week High$7.78
52 Week Low$1.17
52-Week Range
$1.17$7.78
$1.93
Fundamentals
Market Cap$124M
P/E Ratio—
EPS$-0.93
Dividend Yield—
Dividend / Share—
ROE-0.6%
Profit Margin-0.3%
Debt / Equity—
Trading
Volume184K
Avg Volume (10D)—
Shares Outstanding64.8M
About Treace Medical Concepts Inc
Treace Medical Concepts, Inc., an orthopedic medical device company, is dedicated to the design, manufacture, and marketing of biological devices and / or solutions for foot and ankle surgeons in the United States. The company is headquartered in Ponte Vedra Beach, Florida.
HEALTHCAREMEDICAL DEVICES
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICMEDICAL DEVICES
CIK—
Composite FIGI—
Share Class FIGI—